There are currently no headlines for this stock.
AV Therapeutics, Inc. is engaged in the business of developing cancer therapeutics and immunotherapeutic vaccines that can be used alone or in combination with prevalent treatment modalities such as chemotherapy and radiation to treat active disease and to prevent metastases and recurrence. The... More
Sector: Consumer Goods
Industry: Food - Major Diversified
Country: United States
Other News & PR